ArticleHaematologica2017

Circulating microRNA expressions can predict the outcome of lenalidomide plus low-dose dexamethasone treatment in patients with refractory/relapsed multiple myeloma.

Seung-Hyun Jung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.